6 reports

RESEARCH METHODOLOGY ##.

  • Diagnostics
  • Pathology
  • Tuberculosis
  • Alere Inc.
  • Cepheid

One third of the world' s current population has been infected with M. tuberculosis, and new infections occur at a rate of one per second.

  • Tuberculosis
  • United States
  • World
  • Alere Inc.
  • Cepheid

Introduction TB is an infectious disease caused by the bacterium, Mycobacterium tuberculosis.

  • Tuberculosis
  • World
  • Market Size
  • Alere Inc.
  • Cepheid
  • JANSSEN PHARMA ENTERS INTO LICENSING AGREEMENT WITH PHARMSTANDARD FOR BEDAQUILINE, ANTI-TUBERCULOSIS DRUG
  • JANSSEN PHARMA ENTERS INTO AGREEMENT WITH FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS

This agreement enables Janssen Pharma and FIND to accelerate access to tuberculosis (TB) diagnosis, treatment and care.

  • Tuberculosis
  • Belgium
  • United States
  • Company
  • Janssen Biotech, Inc.
  • Infectex Enters Into Licensing Agreement With Qurient For Tuberculosis Drug Q203
  • Jun 22, 2017: Infectex Successfully Completes Phase 1 Clinical Study of Q203 for Treatment of Tuberculosis

" Q## is undergoing intensive phase ## testing and demonstrates excellent results in all studies, including one that is completed by our partner Infectex", - said Dr.

  • Healthcare
  • Pharmaceutical
  • Tuberculosis
  • South Korea
  • Qurient Co., Ltd.
  • August 2016

Q. ##.

  • Diagnostics
  • Healthcare
  • Molecular Diagnostics
  • Tuberculosis
  • Alere Inc.